2023
Assessing the safety of continued perioperative antithrombotic therapy in endoscopic airway surgery for laryngotracheal stenosis
Shah H, Reeder A, Rohrbaugh T, Kohli N. Assessing the safety of continued perioperative antithrombotic therapy in endoscopic airway surgery for laryngotracheal stenosis. American Journal Of Otolaryngology 2023, 44: 103857. PMID: 37030129, PMCID: PMC10033492, DOI: 10.1016/j.amjoto.2023.103857.Peer-Reviewed Original ResearchConceptsEndoscopic airway surgeryAntithrombotic therapyAirway surgeryPerioperative continuationLaryngotracheal stenosisEndoscopic surgeryOpen airway surgeryPerioperative antithrombotic therapyCases of patientsPerioperative cessationPreoperative continuationPostoperative bleedingProlonged intubationAntithrombotic usePrimary outcomeRetrospective studyTracheal stenosisSingle institutionProspective InvestigationInclusion criteriaSurgeryPatientsTherapyComplicationsStenosis
2022
IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial
Kohli N, Lerner M, Rashty J, Kirke D, Stewart T, Blitzer A. IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial. American Journal Of Otolaryngology 2022, 43: 103613. PMID: 36055061, DOI: 10.1016/j.amjoto.2022.103613.Peer-Reviewed Original ResearchConceptsAdductor spasmodic dysphoniaSpasmodic dysphoniaOpen-label clinical trialProspective open-label trialAdductor laryngeal dystoniaOpen-label trialFirst-line treatmentVoice Handicap Index-10Side effect profileTransient side effectsNormal functionVHI-10 scoresIncobotulinumtoxinA injectionsEffect profileLine treatmentSystemic diseaseTA muscleBotulinum toxinClinical trialsLaryngeal dystoniaNursing womenThyroarytenoid muscleInjection sessionsExclusion criteriaSide effects
2021
Adequate short- and long-term pain control with non-opiate analgesics after microdirect laryngoscopy
Bisarya PK, Jiang R, Chao J, Narwani V, Lerner M, Kohli N. Adequate short- and long-term pain control with non-opiate analgesics after microdirect laryngoscopy. American Journal Of Otolaryngology 2021, 43: 103267. PMID: 34695699, DOI: 10.1016/j.amjoto.2021.103267.Peer-Reviewed Original ResearchConceptsAdequate pain controlUse of opioidsPain controlPost-operative painDaily VAS scoresMicrodirect laryngoscopyOpioid medicationsVAS scoresLong-term pain controlSingle-institution prospective studyNon-opiate analgesiaPostoperative pain managementSufficient pain controlPost-operative analgesiaNon-opiate analgesicsVisual analog scaleLong-term painT-testVocal fold lesionsStudent's t-testOpioid analgesiaMost patientsPain managementAnalog scaleProspective study